These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 19372581
1. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP. Karpf AR, Bai S, James SR, Mohler JL, Wilson EM. Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581 [Abstract] [Full Text] [Related]
2. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. Minges JT, Su S, Grossman G, Blackwelder AJ, Pop EA, Mohler JL, Wilson EM. J Biol Chem; 2013 Jan 18; 288(3):1939-52. PubMed ID: 23172223 [Abstract] [Full Text] [Related]
3. Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer. Su S, Parris AB, Grossman G, Mohler JL, Wang Z, Wilson EM. Prostate; 2017 Apr 18; 77(5):505-516. PubMed ID: 27976415 [Abstract] [Full Text] [Related]
4. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene. Schayek H, Bentov I, Sun S, Plymate SR, Werner H. Exp Cell Res; 2010 May 15; 316(9):1479-88. PubMed ID: 20338164 [Abstract] [Full Text] [Related]
5. Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation. Bai S, Grossman G, Yuan L, Lessey BA, French FS, Young SL, Wilson EM. Mol Hum Reprod; 2008 Feb 15; 14(2):107-16. PubMed ID: 18048459 [Abstract] [Full Text] [Related]
6. Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor. Liu Q, Su S, Blackwelder AJ, Minges JT, Wilson EM. J Biol Chem; 2011 Aug 26; 286(34):29951-63. PubMed ID: 21730049 [Abstract] [Full Text] [Related]
7. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins. Su S, Minges JT, Grossman G, Blackwelder AJ, Mohler JL, Wilson EM. J Biol Chem; 2013 Aug 23; 288(34):24809-24. PubMed ID: 23853093 [Abstract] [Full Text] [Related]
8. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, Enokida H, Li LC, Kawakami T, Urakami S, Ribeiro-Filho LA, Terashima M, Fujime M, Igawa M, Dahiya R. Clin Cancer Res; 2005 Feb 01; 11(3):1028-36. PubMed ID: 15709168 [Abstract] [Full Text] [Related]
9. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Bai S, He B, Wilson EM. Mol Cell Biol; 2005 Feb 01; 25(4):1238-57. PubMed ID: 15684378 [Abstract] [Full Text] [Related]
10. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage. Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C. Carcinogenesis; 2013 Feb 01; 34(2):257-67. PubMed ID: 23104178 [Abstract] [Full Text] [Related]
11. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. Mol Endocrinol; 2012 May 01; 26(5):716-35. PubMed ID: 22456196 [Abstract] [Full Text] [Related]
12. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases. Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR. PLoS One; 2011 May 01; 6(11):e27970. PubMed ID: 22114732 [Abstract] [Full Text] [Related]
13. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. Cancer Res; 1998 Dec 01; 58(23):5310-4. PubMed ID: 9850055 [Abstract] [Full Text] [Related]
14. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators. Askew EB, Bai S, Hnat AT, Minges JT, Wilson EM. J Biol Chem; 2009 Dec 11; 284(50):34793-808. PubMed ID: 19828458 [Abstract] [Full Text] [Related]
15. Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer. Titus MA, Zeithaml B, Kantor B, Li X, Haack K, Moore DT, Wilson EM, Mohler JL, Kafri T. PLoS One; 2012 Dec 11; 7(1):e30192. PubMed ID: 22272301 [Abstract] [Full Text] [Related]
16. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G. Oncotarget; 2015 Jun 30; 6(18):16135-50. PubMed ID: 25965833 [Abstract] [Full Text] [Related]
17. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. Ylitalo EB, Thysell E, Landfors M, Brattsand M, Jernberg E, Crnalic S, Widmark A, Hultdin M, Bergh A, Degerman S, Wikström P. Clin Epigenetics; 2021 Jun 30; 13(1):133. PubMed ID: 34193246 [Abstract] [Full Text] [Related]
18. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. Wolff DW, Xie Y, Deng C, Gatalica Z, Yang M, Wang B, Wang J, Lin MF, Abel PW, Tu Y. Int J Cancer; 2012 Apr 01; 130(7):1521-31. PubMed ID: 21500190 [Abstract] [Full Text] [Related]
19. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Takahashi S, Inaguma S, Sakakibara M, Cho YM, Suzuki S, Ikeda Y, Cui L, Shirai T. Prostate; 2002 Jun 01; 52(1):82-8. PubMed ID: 11992622 [Abstract] [Full Text] [Related]
20. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery. Mitsui Y, Shiina H, Hiraki M, Arichi N, Hiraoka T, Sumura M, Honda S, Yasumoto H, Igawa M. Cancer Epidemiol Biomarkers Prev; 2012 Mar 01; 21(3):487-96. PubMed ID: 22246902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]